Pharma giants granted coronavirus approvals but doubts remain on manufacturing a global vaccine

Experts warn that vaccine timelines look ambitious and argue more thought is needed on manufacturing.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.